Jennison Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-690,563
| Closed | -$31.4M | – | 713 |
|
|
2018
Q2 | $31.4M | Sell |
690,563
-7,013
| -1% | -$319K | 0.03% | 333 |
|
|
2018
Q1 | $36.8M | Buy |
697,576
+93,904
| +16% | +$4.96M | 0.04% | 297 |
|
|
2017
Q4 | $41.1M | Buy |
603,672
+3,503
| +0.6% | +$238K | 0.04% | 289 |
|
|
2017
Q3 | $49.5M | Sell |
600,169
-585,008
| -49% | -$48.2M | 0.05% | 274 |
|
|
2017
Q2 | $111M | Buy |
1,185,177
+817,677
| +222% | +$76.6M | 0.12% | 133 |
|
|
2017
Q1 | $23.4M | Sell |
367,500
-82,747
| -18% | -$5.27M | 0.03% | 404 |
|
|
2016
Q4 | $20M | Buy |
450,247
+29,517
| +7% | +$1.31M | 0.02% | 408 |
|
|
2016
Q3 | $15.2M | Buy |
+420,730
| New | +$15.2M | 0.02% | 441 |
|
|
2013
Q3 | – | Sell |
-56,959
| Closed | -$3.82M | – | 721 |
|
|
2013
Q2 | $3.82M | Buy |
+56,959
| New | +$3.82M | ﹤0.01% | 497 |
|